About the Authors
- Anne Louise Bischoff
-
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
- Nilofar Vahman Følsgaard
-
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
- Charlotte Giwercman Carson
-
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
- Jakob Stokholm
-
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
- Louise Pedersen
-
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
- Maria Holmberg
-
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
- Amalie Bisgaard
-
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
- Sune Birch
-
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
- Theodore F. Tsai
-
Affiliation Novartis Vaccines, Cambridge, Massachusetts, United States of America
- Hans Bisgaard
-
* E-mail: bisgaard@copsac.com
Affiliation Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
Competing Interests
TFT is employed by Novartis Vaccines. The nested vaccine study is funded by Novartis Vaccines and Diagnostics GmbH, Marburg, Germany, who provided vaccines and funding as an unrestricted institutional grant. The main Copenhagen Prospective Study on Asthma in Childhood birth cohort study is funded by private and public research funds (see www.copsac.com). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: HB ALB NVF. Performed the experiments: ALB NVF CGC LP JS MH AB. Analyzed the data: ALB SB. Contributed reagents/materials/analysis tools: HB TFT. Wrote the paper: ALB NVF CGC LP JS MH AB SB TFT HB.